Cambridge Healthtech’s Inaugural

Expanding Dx Portfolio for Veterinary Applications

Repurposing Diagnostics from Humans to All Species of Animals

August 20, 2019

 

As the point-of-care testing (POCT) sector is rapidly growing, companies are looking for new market opportunities and ways to increase revenue. With less reimbursement and regulation hurdles to overcome as well as similarities in biology, human diagnostics companies, particularly those in the POCT space, can look to the veterinary space to join the fray. Cambridge Healthtech Institute is proud to offer Expanding Dx Portfolio for Veterinary Applications, where we will discuss ways to repurpose human diagnostic platforms for companion and production animals.

Final Agenda

TUESDAY, AUGUST 20

7:30 am Registration and Morning Coffee

CURRENT TRENDS IN VETERINARY DX SPACE

8:30 Chairperson’s Opening Remarks

Chris Myatt, Founder & CEO, MBio Diagnostics, Inc.

8:40 Case Study: Why Go into Vet DX?

Myatt_ChrisChris Myatt, Founder & CEO, MBio Diagnostics, Inc.

I will discuss the benefits and challenges of designing, manufactoring, and testing human and animal microfluidic diagnostics platforms.

9:10 INTERACTIVE PANEL DISCUSSION: Identifying Current Trends and Opportunities in Veterinary Diagnostics

Myatt_ChrisModerator: Chris Myatt, Founder & CEO, MBio Diagnostics, Inc.


Shu_Kin_So__StephanePanelists: Stephane Shu Kin So, PhD, MBA, CLP, Associate Director, Research Alliances, External Innovation, Zoetis


Khanna_ChandChand Khanna, DVM, PhD, DACVIM (Onc), DACVP (Hon), CSO, Ethos Veterinary Health, President, Ethos Discovery


Avery_anAnne Avery, PhD, VMD, Associate Professor of Immunology, Director of the Clinical Immunology Laboratory Colorado Statue University


Cassell_BrianBrian Cassell, DVM, Chief Strategy Officer, Ethos Veterinary Health

This panel will discuss the trends in precision medicine for companion and livestock animals, the veterinary reference lab landscape and how to deliver advanced veterinary diagnostics.

10:10 Coffee Break in the Exhibit Hall with Poster Viewing

FOCUS ON COMPANION ANIMALS

10:55 Chairperson’s Remarks

Chand Khanna, DVM, PhD, DACVIM (Onc), DACVP (Hon), Chief Science Officer, Ethos Veterinary Health, President, Ethos Discovery

11:00 Intestinal Microbiome Testing in Companion Animals

Suchodolski_JanJan Suchodolski, PhD, AGAF, DACVM, Associate Professor, Gastrointestinal Laboratory, Texas A&M University

It is now recognized that microbiome dysbiosis is a common component of chronic intestinal disease of dogs and cats. For proper assessment of the microbiome in disease, testing needs to address taxonomic and functional changes within gut bacteria. Our laboratory has developed a dysbiosis index to assess changes in the microbiota during treatment and evaluates how microbiota-derived metabolites contribute to intestinal health and disease.

11:30 INTERACTIVE PANEL DISCUSSION: Bridging the Gap between Clinical Vets and Diagnostics Companies

Khanna_ChandModerator: Chand Khanna, DVM, PhD, DACVIM (Onc), DACVP (Hon), CSO, Ethos Veterinary Health, President, Ethos Discovery


Suchodolski_JanPanelists: Jan Suchodolski, PhD, AGAF, DACVM, Associate Professor, Gastrointestinal Laboratory, Texas A&M University


Stewart_SamSamuel Stewart, DVM, DACVECC, Ethos Veterinary Health


 

12:30 pm End of Expanding Dx Portfolio for Veterinary Applications


1:00 Cookie & Refreshment Break in the Exhibit Hall with Poster Viewing

Recommended Short Course*

SC15: Microfluidics and Lab-on-a-Chip Devices for POCT: Technologies and Commercialization

Myatt_ChrisChris Myatt, Founder & CEO, MBio Diagnostics, Inc.

Additional Speakers to be Announced

This short course will provide an overview of microfluidic techniques, including valved and valve-less devices, pumped systems, and capillary flow approaches. Practical examples will keep the discussion grounded in the realization of commercializable devices. We will discuss engineering approaches to enhance the advantages and minimize the challenges. Throughout, the science will be linked to the commercial case for these devices, including a full discussion of a recent success story of a centrifugal microfluidic molecular assay system.

*Separate registration required.